evenfolioETF Details
VanEck·Health·PPH · Nasdaq
VanEck Pharmaceutical ETF (PPH)
- Price
- $119.33
- —30 Oct 2026
- Assets
- $1B
- Total net assets
- Expense ratio
- 0.36%
- Category 1.00%
- Yield
- 1.99%
- Trailing distributions
- 1Y return
- 31.9%+3.1%
- Category 28.8%
- 3Y CAGR
- 19.0%-2.6%
- Category 21.5%
- 5Y CAGR
- 11.8%+7.7%
- Category 4.1%
Loading NAV history…
VanEck Pharmaceutical ETF
Calendar-year returns
Fund only: no comparison series covers this fund's history.
Risk statistics
Five years of daily closes. Risk-free rate 4% a year.
- Standard deviation
- —
- Maximum drawdown
- —
- Sharpe ratio
- —
- Sortino ratio
- —
- Beta
- —
- Alpha
- —
- R²
- —
- Information ratio
- —
- Upside capture
- —
- Downside capture
- —
- Tracking error
- —
| Period | 1M | 3M | 6M | YTD | 1Y | 3YCAGR | 5YCAGR | 10YCAGR | LaunchCAGR |
|---|---|---|---|---|---|---|---|---|---|
| ETF | +9.4% | +8.5% | +17.7% | +17.7% | +31.9% | +19.0% | +11.8% | +10.7% | +6.5% |
| Health average | 3.6% | 9.9% | 23.0% | 20.4% | 28.8% | 21.5% | 4.1% | 10.8% | 11.6% |
| Difference | +5.8% | -1.5% | -5.3% | -2.8% | +3.1% | -2.6% | +7.7% | -0.2% | -5.1% |
Holdings
The 10 largest positions make up 71.5% of the fund.
Top holdings
| Ticker | Holding | Weight |
|---|---|---|
| LLY | Eli Lilly and Co | 20.91% |
| MRK | Merck & Co Inc | 13.51% |
| NVO | Novo Nordisk AS ADR | 5.59% |
| PFE | Pfizer Inc | 5.13% |
| BMY | Bristol-Myers Squibb Co | 4.84% |
| TEVA.TA | Teva Pharmaceutical Industries Ltd | 4.72% |
| GSK | GSK PLC ADR | 4.53% |
| MCK | McKesson Corp | 4.33% |
| COR | Cencora Inc | 4.25% |
| HLN | Haleon PLC ADR | 3.67% |
Portfolio valuation
Weighted averages of what the fund holds.
- P/E
- 25.0
- P/B
- 4.6
- P/S
- 1.5
- P/CF
- 14.9
Sector allocation
Share of the equity the fund holds.
- Health care100.0%
Asset mix
- Stocks99.9%
- Cash0.1%
ETF details
- Issuer
- VanEck
- Category
- Equity · Health
- Ticker
- PPH
- Exchange
- Nasdaq
- Inception
- 20 Dec 2011 (14.9 years)
- Structure
- Exchange Traded Fund
- Expense ratio
- 0.36% (category 1.00%)
- Holdings turnover
- 30% (category 51%)
- Distribution yield
- 1.99%
- Beta, 3 years
- 0.43
- Total net assets
- $1B
Prices and returns as of 30 Oct 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.
Other health ETFs
Other ETFs in the Health category.
- RSPH · Invesco S&P 500 Equal Weight Health Care ETFInvesco · $882.1M · ER 0.40%5Y 5.9%
- PJP · Invesco Pharmaceuticals ETFInvesco · $557.2M · ER 0.58%5Y 11.7%
- XPH · State Street SPDR S&P Pharmaceuticals ETFState Street Investment Management · $524M · ER 0.35%5Y 7.5%
- BBH · VanEck Biotech ETFVanEck · $487.7M · ER 0.35%5Y 5.8%
- PBE · Invesco Biotechnology & Genome ETFInvesco · $423.5M · ER 0.59%5Y 6.9%
- PTH · Invesco Dorsey Wright Healthcare Momentum ETFInvesco · $367M · ER 0.60%5Y 2.5%